Stock Fundamentals

Company Information

Company Name
Vir Biotechnology Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US92764N1028
CIK: 0001706431
CUSIP: 92764N102
Currency: USD
Full Time Employees: 367
Phone: 415 906 4324
Fiscal Year End: December
IPO Date: Oct 11, 2019
Description:

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Address:

1800 Owens Street, San Francisco, CA, United States, 94158

Directors & Officers

Name Title Year Born
Dr. Marianne De Backer M.B.A., M.Sc., Ph.D. President, CEO & Director 1969
Mr. Jason O'Byrne M.B.A. Executive VP & CFO 1969
Ms. Vanina de Verneuil J.D. Executive VP, General Counsel & Corporate Secretary 1979
Dr. Lawrence Corey M.D. Co-Founder & Scientific Advisor 1947
Dr. Louis J. Picker M.D. Co-Founder & Scientific Advisor NA
Mr. Brent Sabatini Senior VP, Principal Accounting Officer & Chief Accounting Officer 1974
Dr. Maninder Hora Ph.D. Executive VP & Chief Technical Operations Officer 1954
Dr. Jennifer Eileen Towne Ph.D. Executive VP & Chief Scientific Officer NA
Dr. Kiki Patel Pharm.D. Head of Investor Relations NA
Ms. Carolyn Wang Senior Vice President of Corporate Communications NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 06, 2026 Backer Marianne De N/A Sale 72.56K $9.16 $664.64K
Apr 01, 2026 Vicki L Sato N/A Sale 22.00K $9.07 $199.54K
Mar 23, 2026 Brent Sabatini N/A Sale 7.71K $9.12 $70.32K
Mar 02, 2026 Vicki L Sato N/A Sale 22.00K $9.51 $209.22K
Feb 25, 2026 Mark Eisner N/A Sale 1.89K $9.82 $18.55K
Feb 25, 2026 Verneuil Vanina De N/A Sale 13.70K $9.82 $134.53K
Feb 24, 2026 Verneuil Vanina De N/A Sale 3.12K $9.53 $29.71K
Feb 24, 2026 Vicki L Sato N/A Sale 42.38K $9.75 $413.18K
Feb 24, 2026 Mark Eisner N/A Sale 1.62K $9.53 $15.40K
Feb 24, 2026 Jason O'byrne N/A Sale 1.63K $9.53 $15.57K
Feb 24, 2026 Brent Sabatini N/A Sale 1.43K $9.53 $13.63K
Feb 24, 2026 Backer Marianne De N/A Sale 14.76K $9.53 $140.68K
Feb 23, 2026 Verneuil Vanina De N/A Sale 4.45K $7.45 $33.12K
Feb 23, 2026 Mark Eisner N/A Sale 2.09K $7.45 $15.56K
Feb 23, 2026 Jason O'byrne N/A Sale 2.09K $7.45 $15.56K
Feb 23, 2026 Backer Marianne De N/A Sale 19.04K $7.45 $141.84K
Feb 23, 2026 Brent Sabatini N/A Sale 1.83K $7.45 $13.63K
Feb 13, 2026 Brent Sabatini N/A Sale 1.53K $7.79 $11.92K
Feb 02, 2026 Vicki L Sato N/A Sale 22.00K $7.71 $169.62K
Jan 02, 2026 Vicki L Sato N/A Sale 22.00K $5.93 $130.46K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 18.00M Mar 31, 2026 10.67% $0.00 10.22%
ARCH VENTURE CORP 12.92M Mar 31, 2026 7.66% $17.09 0.00%
Vanguard Group Inc 12.55M Dec 31, 2025 7.44% $0.00 -1.96%
SB INVESTMENT ADVISERS (UK) LTD 10.95M Mar 31, 2026 6.49% $1.27 -16.53%
Vanguard Portfolio Management, LLC 9.22M Mar 31, 2026 5.46% $0.00 0.00%
GSK PLC 8.55M Mar 31, 2026 5.07% $12.79 0.00%
State Street Corp 7.14M Mar 31, 2026 4.23% $0.00 14.63%
Vanguard Capital Management, LLC 5.38M Mar 31, 2026 3.19% $0.00 0.00%
The Goldman Sachs Group Inc 3.25M Mar 31, 2026 1.93% $0.00 107.17%
Morgan Stanley - Brokerage Accounts 2.85M Mar 31, 2026 1.69% $0.00 6.53%
ADAR1 Capital Management LLC 2.74M Mar 31, 2026 1.63% $1.45 0.00%
Geode Capital Management, LLC 2.66M Mar 31, 2026 1.58% $0.00 14.16%
Dimensional Fund Advisors, Inc. 2.58M Mar 31, 2026 1.53% $0.00 1.71%
Citadel Advisors Llc 2.10M Mar 31, 2026 1.24% $0.00 328.94%
FMR Inc 2.07M Mar 31, 2026 1.23% $0.00 -34.40%
Soleus Capital Management, L.P. 2.00M Mar 31, 2026 1.19% $0.73 0.00%
Point72 Asset Management, L.P. 1.95M Mar 31, 2026 1.16% $0.02 897.47%
Boxer Capital Management, LLC 1.87M Mar 31, 2026 1.11% $2.20 198.56%
Avidity Partners Management LP 1.57M Mar 31, 2026 0.93% $1.59 0.00%
GordonMD Global Investments LP 1.52M Mar 31, 2026 0.90% $9.48 63.23%

Shares Statistics

Shares Outstanding: 168.65M
Shares Float: 128.78M
% Insiders: 659.10%
% Institutions: 8,143.10%
Short % Float: 11.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 6.85M 4.06% ▲ 0.04% May 29, 2026
2 Vanguard Total Stock Mkt Idx Inv 3.98M 2.36% ▲ 0.00% Apr 30, 2026
3 Vanguard Small Cap Index 2.89M 1.72% ▼ 0.36% Apr 30, 2026
4 State Street® SPDR® S&P® Biotech ETF 2.80M 1.66% ▼ 0.61% May 31, 2026
5 iShares Russell 2000 ETF 2.23M 1.32% ▲ 0.93% May 29, 2026
6 FIAM Small Cap Core Composite 1.78M 1.06% ▼ 1.59% Dec 31, 2025
7 Vanguard Small Cap Growth Index Inv 1.62M 0.96% ▼ 0.08% Apr 30, 2026
8 Vanguard Strategic Equity Inv 1.29M 0.77% ▲ 74.29% Mar 31, 2026
9 FIAM Small Cap Core CIT Cl B 1.29M 0.76% ▲ 0.00% Mar 31, 2026
10 Vanguard Institutional Extnd Mkt Idx Tr 1.27M 0.76% ▲ 0.55% Apr 30, 2026

Valuation Metrics

Enterprise Value: $1.07B
Trailing P/E: 0.00
Forward P/E: 4.27

Financial Highlights

Market Cap: $1.45B
EBITDA: $-451.05M
Book Value: $5.49
Earnings/Share: $-3.13
Profit Margin: 0.00%
Operating Margin: 459,241.36%
ROA (TTM): -24.79%
ROE (TTM): -47.69%
Revenue (TTM): $65.50M
Revenue/Share (TTM): $0.47
Earnings Growth (YOY): 58.50%
Revenue Growth (YOY): 417.80%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.54x 0.01x 0.24x N/A -0.02x
2024-12-31 8.71x 0.01x 0.18x N/A -0.02x
2023-12-31 9.05x 0.01x 0.17x N/A -0.02x
2022-12-31 4.93x 0.00x 0.26x 4.55x 0.01x
2021-12-31 4.58x 0.00x 0.27x 1.54x 0.01x
2020-12-31 7.80x 0.01x 0.22x -77.93x 0.01x
2019-12-31 6.81x 0.00x 0.17x -22.34x 0.00x
2018-12-31 2.95x -0.08x 1.94x N/A -0.13x
2017-12-31 15.46x 0.00x 1.27x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about VIR.US!